Evaluation of an E-intervention on MHBC for Chinese Cardiac Patients in Home-based Rehabilitation (NCT03636724) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of an E-intervention on MHBC for Chinese Cardiac Patients in Home-based Rehabilitation
China166 participantsStarted 2021-07-31
Plain-language summary
By using the Health Action Process Approach (HAPA) model as a theoretical backdrop, the proposed study aims to provide a 10-week e-health learning strategies for Chinese cardiac patients, with which they can follow at home after rehabilitation discharge. The current study will examine whether the cardiac rehabilitation patients in intervention group would increase their physical activity (PA) level and fruit-vegetable intake (FVI), improve the social-cognitive variables of PA and FVI, and enhance mental health outcomes in comparison with control condition; and whether the social-cognitive variables would mediate the association between intervention and adopting a healthy lifestyle. The study findings may contribute to the current multiple health behaviour intervention research and support Chinese cardiac patients to maintain rehabilitation outcomes and cultivate a healthy lifestyle.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* no restriction of physical mobility under the cardiac function at entry
* no restriction of relevant diseases such as diabetes or fruit allergies
* As the study involves an online website and mobile phone SMS, only participants with access to the Internet via mobile phone will be enrolled
Exclusion Criteria:
* have restrictions of physical mobility under the cardiac function at entry
* have restrictions of relevant diseases such as diabetes or fruit allergies
* cannot use the Internet and mobile phone
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change of weekly amount of physical activity (PA)
Timeframe: From baseline to the 9th week (at the end of intervention) and 3-month follow-up
2
Change of daily portions of fruit-vegetable intake (FVI)
Timeframe: From baseline to the 9th week (at the end of intervention) and 3-month follow-up